Eligible participant has to fullfill all of the following items | / / / / |
Anyone with one of following items or more should be excluded: | / / / / / / / / / / |
- General information
- Medical history
- Physical examination
- Blood Routine Tests
- Urine Routine Test
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV/HCV/HIV/Syphilis Markers Test
- Renel Function Test
- D-dimer
- hCG Test
- Image Examinations
- Visual Analogue Scale
- Blood Gas Analysis
Date of signing the informed consent | 2024-2-18 |
Date of birth | 1988-11-11 yyyy-mm-dd |
Age | 35 Years |
Education background | Middle school
|
Occupation | Other
|
Other (Description) | 职员 |
间断3天 小时 |
|
无 |
|
Number of pregnancy | 2 次 |
Number of delivery | 2 次 |
If has delivery history, select following items | |
partus maturus | 2 次 |
premature delivery | 0 次 |
abortion | 0 次 |
Last pregnancy | 7年前 yyyy-mm-dd |
Average times of menstrual onset a year | 12 次/年 |
Average menstrual cycle | 30 天(days) |
Menarche time | 14 岁(years) |
The time of last Menstruation | 2024-2-7 年、月、日(yyyy-mm-dd) |
The time of menstrual onset before the last one | 不详 年、月、日(yyyy-mm-dd) |
无 |
|
-- 年/月/日(yyyy-mm-dd) |
|
Namy of the drug to be allergied | 无 |
Vulva | Normal
|
Description in detail for abnormal |
|
Vagina | Normal
|
Description in detail for abnormal |
|
Uterine neck | Normal
|
Description in detail for abnormal |
|
Corpus uteri | Normal
|
Description in detail for abnormal |
|
Adnexa uteri | |
Left side | Abnormal
|
Description in detail for abnormal | 增厚 |
Right side | Normal
|
Description in detail for abnormal | -- |
Weight | 60 kg |
Hight | 1580 mm |
Systolic pressure (SP) | 108 mmHg |
Diastolic pressure | 74 mmHg |
Temperature | 37 degree Celsius |
Pulse rate | 96 次/分 |
Breath frequency | 21 次/分 |
Doctor signature | 刘义彬 |
Date | 2024-2-16 yyyy-mm-dd |
WBC | 8.60 ×109 /L |
NEUT% | 66.65 % |
LY% | 24.24 % |
MONO% | 7.10 % |
RBC | 4.37 ×10^12 /L |
HGB | 136 g/L |
PLT | 270 ×10^9 /L |
Researcher signature | 刘义彬 |
Date | 2024-2-19 yyyy-mm-dd |
Acidity and allkalinity | Acidity
|
pH value | 7.0 |
Urine protein | Negative
|
Urine red cell | Negative
|
Urine WBC | Negative
|
Urine glucos | Negative
|
Urine Bilirubin | Negative
|
Urine HCG | Negative
|
KET | Negative
|
SG | 1.023 |
UBG | Negative
|
NIT | Negative
|
Date of test | 2024-2-19 yyyy-mm-dd |
Date of test | 2024-2-19 yyyy-mm-dd |
K | 4.86 mmol/L |
Na | 140.9 mmol/L |
Cl | 106.2 mmol/L |
Ca | 2.26 mmol/L |
P | 1.07 mmol/L |
Date of examination | 2024-2-19 yyyy-mm-dd |
Prothrombin time | 11.2 秒 |
Thrombin time (TT) | 13.6 秒 |
Activated partial thromboplastin time (APTT) | 29.1 秒 |
Fibrinogen (FIB) | 2.95 g/L |
ALT | 6.0 IU/L |
AST | 13.3 IU/L |
GGT | 21.0 U/L |
Serum bilirubin | 19.6 μmol/L |
Indirect bilirubin | 14.3 umol/L |
Direct bilirubin | 5.3 umol/L |
Serum albumin | 39.4 g/L |
Serum globulin | 24.6 g/L |
Serum total protein | 64.0 g/L |
Date of test | 2024-2-19 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-19 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-19 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-19 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-2-19 yyyy-mm-dd |
SCr | 60.0 μmol/L |
Blood urea | 2.80 mmol/L |
Blood uric acid | 302.0 μmol/L |
Date of test | 2024-2-19 yyyy-mm-dd |
D-dimer value | 0.13 ug/mL |
Date of test | 2024-2-19 |
Urine pregnancy test | Not tested
|
Blood HCG concentration | -- mIU/mL |
Date of test | -- yyyy-mm-dd |
Size of the ulcer | 4.95 cm*cm |
Uterine echo distribution | Even
|
Endometrial thickness | 5.1 mm |
Left ovary size | 3.78*2.59 cm ×cm |
Shape of Left ovary | Ovarian cyst
|
Size of the Ovarian cyst | 3.78*2.59cm低回声实质性回声区 |
Right ovary size | 3.29*1.5 cm ×cm |
Shape of right ovary | Normal
|
Size of Ovarian cyst | -- |
Description of other abnormal findings | -- |
Diagnosis of the Ultrasound B | 左卵巢肿物蒂扭转 |
Doctor signature | 刘义彬 |
Date of examination | 2024-2-18 yyyy-mm-dd |
Pain Visual Analogue Score | Occasionally very slight pain
|
PH | 7.397 |
PCO2 | 39.0 mmHg |
P02 | 239.8 mmHg |
SO2 | 99.4 % |
HCO3 | 23.5 mmol/l |
SBE | -1.2 mmol/l |
LAC | 1.35 mmol/L |
Date of examination | 2024-2-22 (yyyy-mm-dd) |
左附件 |
|
2cm cm |
|
无 ° |
|
刘义彬 |
|
2024-2-22 |
D-dimer value | 0.16 ug/mL |
Date of test | 2024-2-23 |
Body temperature | 37.2 ℃ |
Systolic pressure (SP) | 103 mmHg |
Diastolic pressure (DP) | 63 mmHg |
Heart Rate, HR | 80 次/分 |
Pulse | 80 次/秒 |
WBC | 9.5 ×109 /L |
NEUT% | 68.71 % |
LY% | 19.49 % |
MONO% | 10.48 % |
RBC | 3.98 ×10^12 /L |
HGB | 126 g/L |
PLT | 251 ×10^9 /L |
Date | 2024-2-23 yyyy-mm-dd |
/ | |
Pain Visual Analogue Score | Occasionally very slight pain
|
sample collection | Collected
|
Volume | 2 ml |
Time of collection | 2024-2-18 yyyy-mm-dd-hh-min. |
Label Number of the sample | 2024-2-24 |
Date received at DCC | -- yyyymmdd |
Report type | |
Name of this event | --- |
SAE start date | -- yyyymmdd |
SAE stop date | -- yyyymmdd |
Was this an unanticipated adverse event | |
Attribution to Study Drug | |
Outcome Type(check all that apply) | |
Recovery Description: (check only one) | |
Please provide a brief narrative of the SAE occurrence below | -- |
Name of the recorder | -- |
Data | --- yyyymmdd |
Site Investigator’s signature | -- |
Data | -- yyyymmdd |